Clinical Trial Update: Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study) [Phase 4]

View source ↗

Summary

Phase 4 pediatric post-marketing study of Paxil (paroxetine) for depression in Japan was terminated; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• PAXIL (paroxetine hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder | Phase 4 | Status: TERMINATED | Results posted: 2011-10-13